Drug
Shr A2009 Bevacizumab
Shr A2009 Bevacizumab: highest development phase Phase 3, developed by Suzhou Suncadia Biopharmaceuticals Co., Ltd.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Trials
| Drug | Phase | Indication |
|---|---|---|
| SHR-A2009 + bevacizumab NCT07895992 | Phase 3 | Non-squamous Non-small Cell Lung Cancer |
Latest
No recent events.
Follow Shr A2009 Bevacizumab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.